5 Ergebnisse
BACKGROUND OF THE INVENTION
.sup.18F-labeled O-(2-[.sup.18F]fluoroethyl)-L-Tyrosine is an amino acid tracer, it has been proved as a suitable PET (position emission tomography) probe for tumor diagnosis imaging. Today, 2-[.sup.18F]Fluoro-2-Deoxy-D-glucose([.sup.18F]FDG) has been widely used as a PET
BACKGROUND OF THE INVENTION
Breast cancer is the most common form of cancer in women, resulting in approximately 180,000 new cancer cases annually and causing 18% of cancer-related deaths of women in the United States. It is the second leading cause of cancer-related deaths in humans. Despite recent
FIELD OF THE INVENTION
This invention relates to enteral nutritional products for cancer patients and, more particularly, to enteral nutritional products comprising high fat, low carbohydrate and an elemental amino acid profile having a selected amino acid imbalance for suppressing tumor
BACKGROUND OF THE INVENTION
This invention relates to the diagnosis and treatment of tumors having peptide-specific surface receptors.
Despite the advances in diagnosis and treatment of cancer, surgery remains the most reliable and effective long-term treatment of some types of cancer. The success
The present invention concerns novel amides and their use, in particular their therapeutic use. These compounds have been synthesised and characterised by the present inventor, as disclosed herein. Further, their efficacy as anti-tumour agents has been shown in vitro and in animal studies, disclosed